DBSA Scientific Advisory Board members, Dr. Gregory Simon and Dr. Joseph Calabrese, discuss the limitations of current treatment options for mood disorders and the need within the clinical and patient communities to shift expectations and raise treatment goals to complete remission of symptoms and sustained wellness. Visit http://www.dbsalliance.org/TargetZero for more information on this campaign.

Gregory Simon, MD, MPH

Investigator, Center for Health Studies Group Health Cooperative

Joseph R. Calabrese, MD

Director, Mood Disorders Program, University Hospitals Case Medical Center